255 related articles for article (PubMed ID: 9425044)
1. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
2. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA
Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776
[TBL] [Abstract][Full Text] [Related]
4. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
5. Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1995 Dec; 34(49):15925-33. PubMed ID: 8519749
[TBL] [Abstract][Full Text] [Related]
6. The structure of G117H mutant of butyrylcholinesterase: nerve agents scavenger.
Amitay M; Shurki A
Proteins; 2009 Nov; 77(2):370-7. PubMed ID: 19452557
[TBL] [Abstract][Full Text] [Related]
7. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
8. Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.
Ordentlich A; Barak D; Kronman C; Benschop HP; De Jong LP; Ariel N; Barak R; Segall Y; Velan B; Shafferman A
Biochemistry; 1999 Mar; 38(10):3055-66. PubMed ID: 10074358
[TBL] [Abstract][Full Text] [Related]
9. Screening assays for cholinesterases resistant to inhibition by organophosphorus toxicants.
Wang Y; Schopfer LM; Duysen EG; Nachon F; Masson P; Lockridge O
Anal Biochem; 2004 Jun; 329(1):131-8. PubMed ID: 15136175
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
11. Specificity of ethephon as a butyrylcholinesterase inhibitor and phosphorylating agent.
Haux JE; Lockridge O; Casida JE
Chem Res Toxicol; 2002 Dec; 15(12):1527-33. PubMed ID: 12482234
[TBL] [Abstract][Full Text] [Related]
12. The active site of human paraoxonase (PON1).
Josse D; Lockridge O; Xie W; Bartels CF; Schopfer LM; Masson P
J Appl Toxicol; 2001 Dec; 21 Suppl 1():S7-11. PubMed ID: 11920913
[TBL] [Abstract][Full Text] [Related]
13. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents.
Trovaslet-Leroy M; Musilova L; Renault F; Brazzolotto X; Misik J; Novotny L; Froment MT; Gillon E; Loiodice M; Verdier L; Masson P; Rochu D; Jun D; Nachon F
Toxicol Lett; 2011 Sep; 206(1):14-23. PubMed ID: 21683774
[TBL] [Abstract][Full Text] [Related]
14. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
15. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase and G116H, G116S, G117H, G117N, E197Q and G117H/E197Q mutants: a molecular dynamics study.
Vyas S; Beck JM; Xia S; Zhang J; Hadad CM
Chem Biol Interact; 2010 Sep; 187(1-3):241-5. PubMed ID: 20399202
[TBL] [Abstract][Full Text] [Related]
17. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
18. Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.
Yao Y; Liu J; Zhan CG
Biochemistry; 2012 Nov; 51(44):8980-92. PubMed ID: 23092211
[TBL] [Abstract][Full Text] [Related]
19. Modification of near active site residues in organophosphorus hydrolase reduces metal stoichiometry and alters substrate specificity.
diSioudi B; Grimsley JK; Lai K; Wild JR
Biochemistry; 1999 Mar; 38(10):2866-72. PubMed ID: 10074338
[TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]